New patent for Novo Nordisk drug SAXENDA

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There are fifteen…

The post New patent for Novo Nordisk drug SAXENDA appeared first on DrugPatentWatch Blog.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: